Singapore, July 23 -- Australian scientists will kickstart research into how early vaccine studies can safely support faster approvals of vaccines in response to infectious disease outbreaks.

FEEVA (a Framework for Evidence Evaluation in Vaccine Assessment) is a new collaborative project led by the Kirby Instituteat UNSW Sydney and theAustralian Living Evidence Collaboration(ALEC)at Monash University supported by up to $3 million funding from global health organisations- Coalition for Epidemic Preparedness Innovations (CEPI) and Wellcome.

The first-of-its-kind initiative will work with immunologists, vaccine developers and regulators to explore how early evidence on a vaccine's efficacy could be reviewed by regulators alongside robust s...